Immune to Cancer: The CRI Blog
-
How Immunotherapy Is Making an Impact in Liver Cancer
We spoke with Bruno Sangro, MD, PhD, about the current treatment landscape for patients with liver cancer,…
-
Six CRI-Funded Scientists on Dr. James P. Allison’s Impact on Their Lives and Careers
We spoke with six CRI-funded scientists who have worked in Allison’s lab about their experiences and the impact…
-
David’s Immunotherapy Story
Melanoma | Diagnosed 2014 I am not a statistic. David’s Story Melanoma, that word had always been terrifying… -
ASH18 Preview: Blood Cancer Immunotherapy Developments at 60th American Society of Hematology Meeting
The 2018 American Society of Hematology meeting will showcase a variety of basic and clinical advances in…
-
FDA Approves Pembrolizumab Immunotherapy for Advanced Liver Cancer
Patients with advanced hepatocellular carcinoma (HCC), the most common form of liver cancer, can now receive PD-1…
-
Voices Amongst the Crowd at 2018 TCS New York City Marathon
Sixteen Team CRI runners ran the 26.2 mile 2018 TCS New York City Marathon and raised an…
-
Fundraising and Fighting Cancer with Music for a Cause
On September 28, 2018, Conversing with Oceans organized a concert and fundraiser in the Bronx to support…
-
CRI Celebrates its 65th Birthday
On Thursday, October 25, the Cancer Research Institute held its annual awards gala to celebrate its 65th…
-
CICON18 Day 4 Update: The Role of Bacteria; Technologies to Advance Cancer Immunotherapy
The final day of CICON18 explored two diverse areas—technology and the microbiome—that both have the…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.